Guidelines on the use of biochemical markers of bone turnover in osteoporosis (2001).
Nishizawa
Y
Y
Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan.
Nakamura
T
T
Ohata
H
H
Kushida
K
K
Gorai
I
I
Shiraki
M
M
Fukunaga
M
M
Hosoi
T
T
Miki
T
T
Nakatsuka
K
K
Miura
M
M
D000469:Alkaline Phosphatase / Q000652:urine; D000596:Amino Acids / Q000652:urine*; D015415:Biomarkers / Q000652:urine; D001862:Bone Resorption; D002762:Cholecalciferol / Q000627:therapeutic use; D003094:Collagen / Q000737:chemistry / Q000652:urine*; D024042:Collagen Type I / Q000737:chemistry; D004164:Diphosphonates / Q000627:therapeutic use; D004797:Enzyme-Linked Immunosorbent Assay; D020249:Hormone Replacement Therapy; D006801:Humans; D010024:Osteoporosis / Q000175:diagnosis / Q000628:therapy* / Q000652:urine*; D010455:Peptides / Q000737:chemistry / Q000652:urine*
D000596:Amino Acids; D015415:Biomarkers; D024042:Collagen Type I; D004164:Diphosphonates; D010455:Peptides; C052929:collagen type I trimeric cross-linked peptide; D002762:Cholecalciferol; C036020:deoxypyridinoline; D003094:Collagen; D000469:Alkaline Phosphatase